TY - JOUR AU - Travis, W. D. AU - Costabel, U. AU - Hansell, D. M. PY - 2013 DA - 2013// TI - An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias JO - Am J Respir Crit Care Med VL - 188 UR - https://doi.org/10.1164/rccm.201308-1483ST DO - 10.1164/rccm.201308-1483ST ID - Travis2013 ER - TY - JOUR PY - 2000 DA - 2000// TI - Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) JO - Am J Respir Crit Care Med VL - 161 UR - https://doi.org/10.1164/ajrccm.161.2.ats3-00 DO - 10.1164/ajrccm.161.2.ats3-00 ID - ref2 ER - TY - JOUR AU - Ley, B. AU - Collard, H. R. AU - King, T. E. PY - 2011 DA - 2011// TI - Clinical course and prediction of survival in idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 183 UR - https://doi.org/10.1164/rccm.201006-0894CI DO - 10.1164/rccm.201006-0894CI ID - Ley2011 ER - TY - JOUR AU - Collard, H. R. AU - Moore, B. B. AU - Flaherty, K. R. PY - 2007 DA - 2007// TI - Acute exacerbations of idiopathic pulmonary fibrosis JO - Am J Respir Crit Care Med VL - 176 UR - https://doi.org/10.1164/rccm.200703-463PP DO - 10.1164/rccm.200703-463PP ID - Collard2007 ER - TY - JOUR AU - Park, I. N. AU - Kim, D. S. AU - Shiin, T. S. PY - 2007 DA - 2007// TI - Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis JO - Chest. VL - 132 UR - https://doi.org/10.1378/chest.07-0323 DO - 10.1378/chest.07-0323 ID - Park2007 ER - TY - JOUR AU - Suda, T. AU - Kaida, Y. AU - Nakamura, Y. PY - 2009 DA - 2009// TI - Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2008.12.019 DO - 10.1016/j.rmed.2008.12.019 ID - Suda2009 ER - TY - JOUR AU - Olson, A. L. AU - Huie, T. J. AU - Groshong, S. D. PY - 2008 DA - 2008// TI - Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series JO - Chest. VL - 134 UR - https://doi.org/10.1378/chest.08-0428 DO - 10.1378/chest.08-0428 ID - Olson2008 ER - TY - JOUR AU - Song, J. W. AU - Hong, S. B. AU - Lim, C. M. PY - 2009 DA - 2009// TI - Acute deterioration in idiopathic pulmonary fibrosis: causes, risk factors, and outcomes JO - Respirology. VL - 3 ID - Song2009 ER - TY - JOUR AU - Suzuki, A. AU - Taniguchi, H. AU - Ando, M. PY - 2018 DA - 2018// TI - Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: a retrospective cohort study JO - Clin Respir J VL - 12 UR - https://doi.org/10.1111/crj.12602 DO - 10.1111/crj.12602 ID - Suzuki2018 ER - TY - JOUR AU - Raghu, G. AU - Collard, H. R. AU - Egan, J. J. PY - 2011 DA - 2011// TI - An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management JO - Am J Respir Crit Care Med VL - 183 UR - https://doi.org/10.1164/rccm.2009-040GL DO - 10.1164/rccm.2009-040GL ID - Raghu2011 ER - TY - JOUR AU - Gomi, K. AU - Zushi, M. AU - Honda, G. PY - 1990 DA - 1990// TI - Antithrombotic effect of recombinant human thrombomodulin on thrombin-induced thromboembolism in mice JO - Blood. VL - 75 UR - https://doi.org/10.1182/blood.V75.7.1396.1396 DO - 10.1182/blood.V75.7.1396.1396 ID - Gomi1990 ER - TY - JOUR AU - Nakashima, M. AU - Kanamaru, M. AU - Umemura, K. PY - 1998 DA - 1998// TI - Pharmacokinetics and safety of a novel recombinant soluble human thrombomodulin, ART-123, in healthy male volunteers JO - J Clin Pharmacol VL - 38 UR - https://doi.org/10.1002/j.1552-4604.1998.tb04375.x DO - 10.1002/j.1552-4604.1998.tb04375.x ID - Nakashima1998 ER - TY - JOUR AU - Maruyama, I. PY - 1999 DA - 1999// TI - Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation JO - Thromb Haemost VL - 82 UR - https://doi.org/10.1055/s-0037-1615902 DO - 10.1055/s-0037-1615902 ID - Maruyama1999 ER - TY - JOUR AU - Saito, H. AU - Maruyama, I. AU - Shimazaki, S. PY - 2007 DA - 2007// TI - Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial JO - J Thromb Haemost VL - 5 UR - https://doi.org/10.1111/j.1538-7836.2006.02267.x DO - 10.1111/j.1538-7836.2006.02267.x ID - Saito2007 ER - TY - JOUR AU - Ogawa, Y. AU - Yamakawa, K. AU - Ogura, H. PY - 2012 DA - 2012// TI - Recombinant human soluble thrombomodulin improves mortality and respiratory dysfunction in patients with severe sepsis JO - J Trauma Acute Care Surg VL - 72 UR - https://doi.org/10.1097/TA.0b013e3182516ab5 DO - 10.1097/TA.0b013e3182516ab5 ID - Ogawa2012 ER - TY - JOUR AU - Uba, T. AU - Nishi, K. AU - Takeshi, O. PY - 2017 DA - 2017// TI - The influence of human soluble recombinant thrombomodulin on in-hospital mortality in patients with acute respiratory distress syndrome and disseminated intravascular coagulation: a retrospective multicenter study JO - J Intensive Crit Care VL - 3 UR - https://doi.org/10.21767/2471-8505.100099 DO - 10.21767/2471-8505.100099 ID - Uba2017 ER - TY - JOUR AU - Ware, L. B. AU - Matthay, M. A. PY - 2000 DA - 2000// TI - The acute respiratory distress syndrome JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200005043421806 DO - 10.1056/NEJM200005043421806 ID - Ware2000 ER - TY - JOUR AU - Moher, D. AU - Liberati, A. AU - Tetzlaff, J. PY - 2009 DA - 2009// TI - Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement JO - Ann Intern Med VL - 151 UR - https://doi.org/10.7326/0003-4819-151-4-200908180-00135 DO - 10.7326/0003-4819-151-4-200908180-00135 ID - Moher2009 ER - TY - STD TI - Suzuki A, Kondoh Y, Brown KK, et al. Acute exacerbations of fibrotic interstitial lung diseases. Respirology. 2019. https://doi.org/10.1111/resp.13682. ID - ref19 ER - TY - JOUR AU - Raghu, G. AU - Remy-Jardin, M. AU - Myers, J. L. PY - 2018 DA - 2018// TI - Diagnosis of idiopathic pulmonary fibrosis: an official ATS/ERS/JRS/ALAT clinical practice guideline JO - Am J Respir Crit Care Med VL - 198 UR - https://doi.org/10.1164/rccm.201807-1255ST DO - 10.1164/rccm.201807-1255ST ID - Raghu2018 ER - TY - STD TI - Taniguchi H, Kondoh Y. Revised criteria for acute exacerbation of idiopathic pulmonary fibrosis. Annu Rep Study Group Minist Health Welf Diffuse Lung Dis. 2004:114–9. ID - ref21 ER - TY - JOUR AU - Collard, H. R. AU - Ryerson, C. J. AU - Corte, T. J. PY - 2016 DA - 2016// TI - Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report JO - Am J Respir Crit Care Med VL - 194 UR - https://doi.org/10.1164/rccm.201604-0801CI DO - 10.1164/rccm.201604-0801CI ID - Collard2016 ER - TY - JOUR AU - Hagiwara, A. AU - Tanaka, N. AU - Uemura, T. PY - 2016 DA - 2016// TI - Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-Centre, open-label, randomised controlled trial JO - BMJ Open VL - 6 UR - https://doi.org/10.1136/bmjopen-2016-012850 DO - 10.1136/bmjopen-2016-012850 ID - Hagiwara2016 ER - TY - STD TI - American Thoracic Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2002;165:277–304. ID - ref24 ER - TY - STD TI - Qiu M, Chen Y, Ye Q. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Respir J. 2017;23:23. ID - ref25 ER - TY - JOUR AU - Yamakawa, K. AU - Aihara, M. AU - Ogura, H. PY - 2015 DA - 2015// TI - Recombinant human soluble thrombomodulin in severe sepsis: a systematic review and meta-analysis JO - J Thromb Haemost VL - 13 UR - https://doi.org/10.1111/jth.12841 DO - 10.1111/jth.12841 ID - Yamakawa2015 ER - TY - JOUR AU - Kamiya, H. AU - Panlaqui, O. M. PY - 2019 DA - 2019// TI - A systematic review of the efficacy of direct hemoperfusion with a polymyxin B-immobilized fibre column to treat rapidly progressive interstitial pneumonia JO - SAGE Open Med VL - 7 UR - https://doi.org/10.1177/2050312119861821 DO - 10.1177/2050312119861821 ID - Kamiya2019 ER - TY - JOUR AU - Sterne, J. A. AU - Hernan, M. A. AU - Reeves, B. C. PY - 2016 DA - 2016// TI - ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions JO - BMJ. VL - 355 UR - https://doi.org/10.1136/bmj.i4919 DO - 10.1136/bmj.i4919 ID - Sterne2016 ER - TY - STD TI - Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from: http://www.handbook.cochrane.org. UR - http://www.handbook.cochrane.org ID - ref29 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ. VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Isshiki, T. AU - Sakamoto, S. AU - Kinoshita, A. PY - 2015 DA - 2015// TI - Recombinant human soluble thrombomodulin treatment for acute exacerbation of idiopathic pulmonary fibrosis: a retrospective study JO - Respir. VL - 89 UR - https://doi.org/10.1159/000369828 DO - 10.1159/000369828 ID - Isshiki2015 ER - TY - JOUR AU - Sakamoto, S. AU - Shimizu, H. AU - Isshiki, T. PY - 2018 DA - 2018// TI - Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a historically controlled study JO - Respir Investig VL - 56 UR - https://doi.org/10.1016/j.resinv.2017.10.004 DO - 10.1016/j.resinv.2017.10.004 ID - Sakamoto2018 ER - TY - JOUR AU - Arai, T. AU - Kida, H. AU - Ogata, Y. PY - 2019 DA - 2019// TI - Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias JO - Respirology. VL - 24 UR - https://doi.org/10.1111/resp.13514 DO - 10.1111/resp.13514 ID - Arai2019 ER - TY - JOUR AU - Abe, M. AU - Tsushima, K. AU - Matsumura, T. PY - 2015 DA - 2015// TI - Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study JO - Drug Des Devel Ther VL - 9 ID - Abe2015 ER - TY - JOUR AU - Abe, T. AU - Yokomura, K. AU - Goto, A. PY - 2016 DA - 2016// TI - Efficacy of recombinant human thrombomodulin α in acute exacerbation of idiopathic pulmonary fibrosis JO - Nihon Kokyuki Gakkai Zasshi VL - 5 ID - Abe2016 ER - TY - JOUR AU - Hayakawa, S. AU - Matsuzawa, Y. AU - Irie, T. PY - 2016 DA - 2016// TI - Efficacy of recombinant human soluble thrombomodulin for the treatment of acute exacerbation of idiopathic pulmonary fibrosis: a single arm, non-randomized prospective clinical trial JO - Multidscip Respir Med VL - 11 UR - https://doi.org/10.1186/s40248-016-0074-z DO - 10.1186/s40248-016-0074-z ID - Hayakawa2016 ER - TY - JOUR AU - Tsushima, K. AU - Yamaguchi, K. AU - Kono, Y. PY - 2014 DA - 2014// TI - Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study JO - Pulm Pharmacol Ther VL - 29 UR - https://doi.org/10.1016/j.pupt.2014.04.008 DO - 10.1016/j.pupt.2014.04.008 ID - Tsushima2014 ER - TY - JOUR AU - Kataoka, K. AU - Taniguchi, H. AU - Kondoh, Y. PY - 2015 DA - 2015// TI - Recombinant human thrombomodulin in acute exacerbation of idiopathic pulmonary fibrosis JO - Chest. VL - 148 UR - https://doi.org/10.1378/chest.14-2746 DO - 10.1378/chest.14-2746 ID - Kataoka2015 ER - TY - JOUR AU - Churg, A. AU - Wright, J. L. AU - Tazelaar, H. D. PY - 2011 DA - 2011// TI - Acute exacerbations of fibrotic interstitial lung disease JO - Histopathol. VL - 58 UR - https://doi.org/10.1111/j.1365-2559.2010.03650.x DO - 10.1111/j.1365-2559.2010.03650.x ID - Churg2011 ER - TY - JOUR AU - Parambil, J. G. AU - Myers, J. L. AU - Aubry, M. C. PY - 2007 DA - 2007// TI - Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy JO - Chest. VL - 132 UR - https://doi.org/10.1378/chest.07-0104 DO - 10.1378/chest.07-0104 ID - Parambil2007 ER - TY - JOUR AU - Esmon, C. T. PY - 1987 DA - 1987// TI - The regulation of natural anticoagulant pathways JO - Sci. VL - 235 UR - https://doi.org/10.1126/science.3029867 DO - 10.1126/science.3029867 ID - Esmon1987 ER - TY - JOUR AU - Mosnier, L. O. AU - Zlokovic, B. V. AU - Griffin, J. H. PY - 2007 DA - 2007// TI - The cytoprotective protein C pathway JO - Blood. VL - 109 UR - https://doi.org/10.1182/blood-2006-09-003004 DO - 10.1182/blood-2006-09-003004 ID - Mosnier2007 ER - TY - JOUR AU - Esmon, C. T. PY - 2005 DA - 2005// TI - The interactions between inflammation and coagulation JO - Br J Haematol VL - 131 UR - https://doi.org/10.1111/j.1365-2141.2005.05753.x DO - 10.1111/j.1365-2141.2005.05753.x ID - Esmon2005 ER - TY - JOUR AU - Li, Y. H. AU - Kuo, C. H. AU - Shi, G. Y. PY - 2012 DA - 2012// TI - The role of thrombomodulin lectin-like domain in inflammation JO - J Biomed Sci VL - 19 UR - https://doi.org/10.1186/1423-0127-19-34 DO - 10.1186/1423-0127-19-34 ID - Li2012 ER - TY - JOUR AU - Okamoto, T. AU - Tanigami, H. AU - Suzuki, K. PY - 2012 DA - 2012// TI - Thrombomodulin: a bifunctional modulator of inflammation and coagulation in sepsis JO - Crit Care Res Pract VL - 2012 ID - Okamoto2012 ER - TY - JOUR AU - Ueno, H. AU - Matsuda, T. AU - Hashimoto, S. PY - 2004 DA - 2004// TI - Contributions of high mobility group box protein in experimental and clinical acute lung injury JO - Am J Respir Crit Care Med VL - 170 UR - https://doi.org/10.1164/rccm.200402-188OC DO - 10.1164/rccm.200402-188OC ID - Ueno2004 ER - TY - STD TI - Yamaguchi K, Iwamoto H, Sakamoto S, et al. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis. Respirology. 2020;25:275–80. https://doi.org/10.1111/resp.13634. ID - ref47 ER - TY - JOUR AU - Faust, S. N. AU - Levin, M. AU - Harrison, O. B. PY - 2001 DA - 2001// TI - Dysfunction of endothelial protein C activation in severe meningococcal sepsis JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJM200108093450603 DO - 10.1056/NEJM200108093450603 ID - Faust2001 ER - TY - JOUR AU - Orwoll, B. E. AU - Spicer, A. C. AU - Zinter, M. S. PY - 2015 DA - 2015// TI - Elevated soluble thrombomodulin is associated with organ failure and mortality in children with acute respiratory distress syndrome (ARDS): a prospective observational cohort study JO - Crit Care VL - 19 UR - https://doi.org/10.1186/s13054-015-1145-9 DO - 10.1186/s13054-015-1145-9 ID - Orwoll2015 ER - TY - JOUR AU - Suzuki, A. AU - Taniguchi, H. AU - Kondoh, Y. PY - 2017 DA - 2017// TI - Soluble thrombomodulin in bronchoalveolar lavage fluid is an independent predictor of severe drug-induced lung injury JO - Respirology. VL - 22 UR - https://doi.org/10.1111/resp.12965 DO - 10.1111/resp.12965 ID - Suzuki2017 ER - TY - JOUR AU - Esmon, C. T. PY - 1989 DA - 1989// TI - The roles of protein C and thrombomodulin in the regulation of blood coagulation JO - J Biol Chem VL - 264 ID - Esmon1989 ER - TY - STD TI - Ebina M, Taniguchi H, Miyasho T, et al. Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis. Pulm Med. 2011;2011. ID - ref52 ER - TY - JOUR AU - Vincent, J. L. AU - Francois, B. AU - Zabolotskikh, I. PY - 2019 DA - 2019// TI - Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: the SCARLET randomized clinical trial JO - JAMA. VL - 321 UR - https://doi.org/10.1001/jama.2019.5358 DO - 10.1001/jama.2019.5358 ID - Vincent2019 ER - TY - JOUR AU - Yamakawa, K. AU - Murao, S. AU - Aihara, M. PY - 2019 DA - 2019// TI - Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis JO - Thromb Haemost VL - 119 UR - https://doi.org/10.1055/s-0038-1676345 DO - 10.1055/s-0038-1676345 ID - Yamakawa2019 ER - TY - JOUR AU - Ranieri, V. M. AU - Thompson, B. T. AU - Barie, P. S. PY - 2012 DA - 2012// TI - Drotrecogin alfa (activated) in adults with septic shock JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1202290 DO - 10.1056/NEJMoa1202290 ID - Ranieri2012 ER - TY - JOUR AU - Inokuma, S. PY - 2011 DA - 2011// TI - Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury JO - Expert Opin Drug Saf VL - 10 UR - https://doi.org/10.1517/14740338.2011.560835 DO - 10.1517/14740338.2011.560835 ID - Inokuma2011 ER - TY - JOUR AU - Koga, T. AU - Fujikawa, K. AU - Horai, Y. PY - 2012 DA - 2012// TI - The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM JO - Rheumatol. VL - 51 UR - https://doi.org/10.1093/rheumatology/ker518 DO - 10.1093/rheumatology/ker518 ID - Koga2012 ER - TY - STD TI - Clinical study of ART-123 for the treatment of acute exacerbation of idiopathic pulmonary fibrosis. http://clinicaltrials.gov/ct2/show/NCT02739165?cond =Thrombomodulin&rank=3. Accessed 23 September 2019. UR - http://clinicaltrials.gov/ct2/show/NCT02739165?cond ID - ref58 ER - TY - JOUR AU - Cornet, A. D. AU - Groeneveld, A. B. AU - Hofstra, J. J. PY - 2014 DA - 2014// TI - Recombinant human activated protein C in the treatment of acute respiratory distress syndrome: a randomized clinical trial JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0090983 DO - 10.1371/journal.pone.0090983 ID - Cornet2014 ER -